Key Patient Considerations for the Utilization of Intravenous and Subcutaneous Therapies : Episode 5
Incorporating Patient Perspectives When Determining a Route of Administration for Biologic Therapies
Jill Zouzoulas, M.D., FACR, describes the best practices for incorporating patient perspectives when determining the ideal route of administration for those with rheumatologic diseases.
Video content above is prompted by the following questions:
- How do you evaluate the costs between IV vs. subcutaneous therapies when deciding which route of administration to use in patients?
- Patient perspectives have been analyzed in those taking IV biologics for rheumatoid arthritis. What did the results show, and do they factor into your treatment decisions?
Recent Videos
Related Content
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
October 7th 2024Article
Jill Zouzoulas, M.D., of Tryon Medical Partners in Charlotte, North Carolina, and Jennifer Seminerio, M.D., of University of Southern Florida Health in Tampa, Florida, discussed the biologics and the pros and cons of the intravenous and subcutaneous delivery methods in Managed Healthcare Executive’s K-Cast video series.
Read More
